ArticlePharmacology research & perspectives2024
Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans.
Donghong Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it